ACE inhibitor therapy: Possible effective prevention of new-onset atrial fibrillation following cardiac surgery

Cardiology Journal

Volumn 14, Issue 3, 2007, Pages 274-281

  Dabrowski, Rafał ^a   Sosnowski, Cezary ^a   Jankowska, Agnieszka ^a   Religa, Grzegorz ^a   Kowalik, Ilona ^a   Szwed, Hanna ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Angiotensin converting enzyme inhibitors; Atrial fibrillation; Beta blockers; Cardiovascular surgery

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; DISEASE DURATION; DRUG CHOICE; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART RATE; HEART SURGERY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OPERATION DURATION; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; RISK FACTOR; RISK REDUCTION; UNIVARIATE ANALYSIS;

EID: 34547887639     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Mitchell LB. Incidence, timing and outcome of atrial tachyarrhythmias after cardiac surgery. In: Steinberg JS ed. Atrial fibrillation alter cardiac surgery. Kluwer Academic Publishers 2000: 37-50.
2. Hillerman DE, Hunter CB, Mohiuddin SM, Maciejewski S. Pharmacological management of atrial fibrillation following cardiac surgery. Am J Cardiovasc Drugs, 2005; 5: 361-369.
3. Mattson SE, Ganz LI. Understanding the pathophysiology of atrial fibrillation from clinical observations. In: Steinberg JS ed. Atrial fibrillation after cardiac surgery. Kluwer Academic Publishers 2000: 19-36.
4. Bharucha DB, Kowey PR. Management and prevention of atrial fibrillation after cardiovascular surgery. Am J Cardiol, 2000; 85: D-20-D-24.
5. Kowey PR, Taylor JE, Rials SJ, Marinchak RA. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol, 1992; 69: 963-965.
6. Andrews TC, Reimold SC, Berlin JA, Antman EA. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomised control trials. Circulation, 1991; 84 (suppl. III): III-236-III-244.
7. Fox KM, Bertrand M, Ferrari R, Remme WJ, Simmons ML. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary disease: randomized, double-blind, placebo controlled, multicentre trial (the EUROPA study): Lancet, 2003; 362: 782-88.
8. Bharati S, Lev M. Histology of the normal and diseased atrium. In: Falk RH, Podrid PJ eds. Atrial fibrillation: mechanisms and management. Raven Press, New York 1992: 15-39.
9. Goette A, Juenemann G, Peters B, Klein HU, Roessner A, Huth C. Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery. Cardiovasc Res, 2002; 54: 390-396.
10. Leitch MS, Thomson D, Baird DK, Harris PJ. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg, 1990; 100: 338-344.
11. Mathew JP, Parks R, Savino JS et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilisation. Multicenter Study of Perioperative Ischemia Research Group. J Am Med Assoc, 1996; 276: 300-306.
12. Amar D, Zhang H, Miodownik S, Kadish AH. Competing autonomic mechanisms precede the onset of postopertive atrial fibrillation. J Am Cardiol, 2003; 42: 1262-1268.
13. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J, 2004, 25. 363-370.
14. Lindsay BD, Smith JM. Electrophysiologic aspects of human atrial fibrillation. Cardiol Clin, 1996; 14: 483-505.
15. Kalman JM, Munawar M, Howes LG et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg, 1995; 60: 1709-1715.
16. Kempf FC, Hedberg A, Molinoff P, Josephson ME. The effects of pharmacologic therapy on atrial beta-receptor density and postoperative atrial arrhythmias. Circulation, 1983; 68 (suppl. III): III-57.
17. Frost L, Molgaard H, Christiansen EH, Hjortholm K, Paulsen PK, Thomsen PE. Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventive trials. Inter J Cardiol, 1992; 36: 253-261.
18. Sanchez JE, Epstein AE. Prophylactic value of beta-blockers. In: Steinberg JS ed. Atrial fibrillation after cardiac surgery. Kluwer Academic Publishers 2000: 95-107.
19. Parikka H, Toivonen L, Heikkila L, Virtanen K, Jarvinan A. Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. J Cardiovasc Pharmacol, 1988; 31: 67-73.
20. Goette A, Lendeckel U, Klein HU. Signal transduction systems and atrial fibrillation. Cardiovasc Res, 2002, 54: 247-258.
21. Goette A, Staack T, Rocken C et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol, 2000; 35: 1669-1677.
22. Macrez N, Morel JL, Kalkbrenner F, Viard P, Schultz G, Mironneau J. A beta-gamma dimer derived from G13 transduces the angiotensin AT1 receptor signal stimulation of Ca2 + channels in rat portal vein myocytes. J Biol Chem, 1997; 272: 23180-23185.
23. Clement-Chomienne O, Walsh MP, Cole WC. Angiotensin II activation of protein kinase C decreases delayed rectifier K current in rabbit vascular myocytes. J Physiol (Lond), 1996; 495: 689-700.
24. De Mello WC, Crespo MJ. Correlation between changes in morphology, electrical properties and angiotensin converting enzyme activity in the failing heart. Eur J Pharmacol, 1999; 378: 178-194.
25. Nakashima H, Kumagai K, Utrata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodelling in atrial fibrillation. Circulation, 2000; 101: 2612-2617.
26. Musgrave Foucart IFS, Majewski H. Evidence that angiotensin II enhances noradrenaline releases from sympathetic nerves in mouse atria by activating protein kinase C. J Auton Pharmacol, 1991; 11: 211-221.
27. Asano K, Dutcher DL, Port D, Minobe WA, Tremmel KD, Roden RL. Selective downregulation of the angiotensin II AT-1 receptor subtype in failing human ventricular myocardium. Circulation, 1997; 95: 1193-1200.
28. Shi Y, Li D, Tardif J-C, Nattel S. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res, 2002; 54: 456-461.
29. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation, 1999; 100: 376-380.
30. Dabrowski R, Jankowska A, Kowalik I. Angiotensin-converting enzyme inhibitor and beta-blocker therapy: possible effective prophylaxis of post-discharge new-onset atrial fibrillation following cardiac surgery. Eur Heart J, 2003; 24: 40.
31. Mathew JP, Fontes ML, Tudor IC et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA, 2004; 291: 1720-1729.